
1. Cell Mol Immunol. 2021 Dec;18(12):2679-2681. doi: 10.1038/s41423-021-00795-5.
Epub 2021 Nov 15.

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with
chronic hepatitis B virus infection.

Xiang T(#)(1)(2), Liang B(#)(1)(2), Wang H(#)(1)(2), Quan X(1)(2), He S(1)(2),
Zhou H(1)(2), He Y(1)(2), Yang D(1)(2), Wang B(3)(4), Zheng X(5)(6).

Author information: 
(1)Department of Infectious Diseases, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, China.
(2)Joint International Laboratory of Infection and Immunity, Huazhong University 
of Science and Technology, Wuhan, China.
(3)Department of Infectious Diseases, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, China. bjwang73@163.com.
(4)Joint International Laboratory of Infection and Immunity, Huazhong University 
of Science and Technology, Wuhan, China. bjwang73@163.com.
(5)Department of Infectious Diseases, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, China. xin11@hotmail.com.
(6)Joint International Laboratory of Infection and Immunity, Huazhong University 
of Science and Technology, Wuhan, China. xin11@hotmail.com.
(#)Contributed equally

DOI: 10.1038/s41423-021-00795-5 
PMCID: PMC8591435
PMID: 34782756 

